Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00839410
What this trial is testing

Multicentric Cohort of Melanoma Patients in Ile de France Area

Who this might be right for
MelanomaGenetic Polymorphism
Assistance Publique - Hôpitaux de Paris 1,255
Testing effectiveness (Phase 2)Study completedNCT00462982
What this trial is testing

Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer
Memorial Sloan Kettering Cancer Center 8
Not applicableStudy completedNCT03693378
What this trial is testing

IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Who this might be right for
Pancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Immunovia, Inc. 1,349
Not applicableEnded earlyNCT03407040
What this trial is testing

Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy

Who this might be right for
Gastrointestinal CancersBreast CancerPancreatic Cancer+2 more
National Cancer Institute (NCI) 98
Large-scale testing (Phase 3)Looking for participantsNCT02000089
What this trial is testing

The Cancer of the Pancreas Screening-5 CAPS5)Study

Who this might be right for
Pancreas CancerPeutz-Jeghers Syndrome (PJS)Gene Mutation+2 more
Johns Hopkins University 9,000
Testing effectiveness (Phase 2)Ended earlyNCT01559818
What this trial is testing

A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001

Who this might be right for
Malignant Melanoma
Immodulon Therapeutics Ltd 10
Early research (Phase 1)Ended earlyNCT03399448
What this trial is testing

NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)

Who this might be right for
Multiple MyelomaMelanomaSynovial Sarcoma+1 more
University of Pennsylvania 3
Not applicableStudy completedNCT00816374
What this trial is testing

Tailored Intervention for Melanoma Patient's Families

Who this might be right for
Melanoma
Fox Chase Cancer Center 553
Not applicableLooking for participantsNCT03809585
What this trial is testing

Observational Study of Iris Tumors

Who this might be right for
Iris Tumor
Oregon Health and Science University 100
Not applicableStudy completedNCT02874040
What this trial is testing

Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)

Who this might be right for
Uveal MelanomaMelanoma, Uveal
Institut Curie 87
Not applicableLooking for participantsNCT05029791
What this trial is testing

Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients

Who this might be right for
Melanoma
Hospices Civils de Lyon 100
Not applicableStudy completedNCT01482260
What this trial is testing

Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma

Who this might be right for
Cutaneous Malignant Melanoma
Ruhr University of Bochum 21
Early research (Phase 1)Active Not RecruitingNCT01955460
What this trial is testing

Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+3 more
M.D. Anderson Cancer Center 34
Early research (Phase 1)WithdrawnNCT02210104
What this trial is testing

Adoptive Therapy Using Antigen-Specific CD4 T-Cells

Who this might be right for
MelanomaSarcoma
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT01703507
What this trial is testing

Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 17
Testing effectiveness (Phase 2)UnknownNCT00925314
What this trial is testing

Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma

Who this might be right for
Stage IIIB Skin MelanomaStage IIIC Skin Melanoma
Cosmo Bioscience 20
Not applicableStudy completedNCT00341991
What this trial is testing

Molecular Epidemiology of Cutaneous Malignant Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 15,401
Early research (Phase 1)Study completedNCT01066390
What this trial is testing

A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bart Neyns 18
Testing effectiveness (Phase 2)Study completedNCT02431676
What this trial is testing

Survivorship Promotion In Reducing IGF-1 Trial

Who this might be right for
Breast CancerProstate CancerLung Cancer+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Not applicableStudy completedNCT07431489
What this trial is testing

Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors

Who this might be right for
Malignant MelanomaMEK Inhibitor-Associated Retinopathy
Institute of Oncology Ljubljana 30
Next Page